FAQ Module

Share

Program Content

Activities

  • Myeloma New Agents FAQ
    Integrating New Agents to Optimize Multiple Myeloma Care: Expert Answers to Frequently Asked Questions
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 09, 2018

    Expires: March 08, 2019

Faculty

cover img faculity

Melissa Alsina, MD

Head, Multiple Myeloma BMT Program
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

cover img faculity

Raymond L. Comenzo, MD

Director, Blood Bank and Stem Cell Processing Laboratory
Tufts Medical Center
Professor of Medicine and Pathology
Tufts University School of Medicine
Boston, Massachusetts

cover img faculity

Jonathan L. Kaufman, MD

Assistant Professor
Winship Cancer Institute
Emory University
Atlanta, Georgia

cover img faculity

Amrita Krishnan, MD, FACP

Director 
Judy Bernard Briskin Center for Myeloma
Executive Director
Professor
Hematology City of Hope Irvine
Duarte, California

Provided by

ProCE Banner

Supporters

Celgene

Karyopharm Therapeutics

Takeda Oncology